Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab-Reference-Cited by-同舟云学术

Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab

Published:2016-08-01 Issue:8 Volume:2 Page:1040
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Loi Sherene¹,Dafni Urania²,Karlis Dimitris³,Polydoropoulou Varvara⁴,Young Brandon M.⁵,Willis Scooter⁵,Long Bradley⁶,de Azambuja Evandro⁷,Sotiriou Christos⁸,Viale Giuseppe⁹,Rüschoff Josef¹⁰,Piccart Martine J.¹¹,Dowsett Mitch¹²,Michiels Stefan¹³,Leyland-Jones Brian⁵

Affiliation:

1. Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia

2. Frontier Science Foundation– Hellas, Athens, Greece3University of Athens, Athens, Greece

3. Frontier Science Foundation– Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece

4. Frontier Science Foundation– Hellas, Athens, Greece

5. Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota

6. Department of Pathology, University of Chicago, Chicago, Illinois

7. BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium

8. Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium

9. University of Milan, European Institute of Oncology, Milan, Italy

10. Targos Molecular Pathology GmbH, Kassel, Germany

11. Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium

12. Royal Marsden Hospital, London, England

13. INSERM U1018 CESP, Service de Biostatistique et d’Epidémiologie, Villejuif, France

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Assessment of Immune Phenotype and Its Effects on Survival Outcomes in HER2-Low versus HER2-Zero Breast Cancer;Breast Cancer: Targets and Therapy;2024-08

2. Analysis of Factors Associated With Pathological Complete Response in Patients With HER2-Positive Breast Cancer Receiving Neoadjuvant Chemotherapy;Clinical Breast Cancer;2024-08

3. The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer;Cancer Treatment Reviews;2024-07

4. Emerging treatments in HER2-positive advanced breast cancer: Keep raising the bar;Cell Reports Medicine;2024-06

5. heredERA Breast Cancer: a phase III, randomized, open-label study evaluating the efficacy and safety of giredestrant plus the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with previously untreated HER2-positive, estrogen receptor-positive locally advanced or metastatic breast cancer;BMC Cancer;2024-05-24